Klein, Eric A.

Selected publications

An Approach Using PSA Levels of 1.5 ng/mL as the Cutoff for Prostate Cancer Screening in Primary Care. Urology. 2016 Academic Article GET IT
Times cited: 9
A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score. European Urology. 2016 Academic Article GET IT
Times cited: 524
Three new pancreatic cancer susceptibility signals identified on chromosomes 1q32.1, 5p15.33 and 8q24.21. Oncotarget. 2016 Academic Article GET IT
Times cited: 29
Biology of Human Tumors Development and clinical validation of an in situ biopsy-based multimarker assay for risk stratification in prostate cancer. Clinical Cancer Research. 2015 Academic Article GET IT
Times cited: 65
Nomogram predicting prostate cancer-specific mortality for men with biochemical recurrence after radical prostatectomy. European Urology. 2015 Academic Article GET IT
Times cited: 64
Do margins matter? the influence of positive surgical margins on prostate cancer-specific mortality. European Urology. 2014 Academic Article GET IT
Times cited: 49
Evaluating the Prostate Cancer Prevention Trial High Grade prostate cancer risk calculator in 10 international biopsy cohorts: Results from the prostate biopsy collaborative group. World Journal of Urology. 2014 Academic Article GET IT
Times cited: 22
Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer. Nature Genetics. 2014 Review GET IT
Times cited: 134
A multi-institutional evaluation of active surveillance for low risk prostate cancer. Journal of Urology. 2013 Academic Article GET IT
Times cited: 56
Evaluation of vitamin e and selenium supplementation for the prevention of bladder cancer in SWOG coordinated SELECT. Journal of Urology. 2012 Academic Article GET IT
Times cited: 31
Evaluating the PCPT risk calculator in ten international biopsy cohorts: Results from the Prostate Biopsy Collaborative Group. World Journal of Urology. 2012 Academic Article GET IT
Times cited: 50
Importance of prostate volume in the European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators: Results from the prostate biopsy collaborative group. World Journal of Urology. 2012 Academic Article GET IT
Times cited: 59
Surgery confounds biology: The predictive value of stage-, grade- and prostate-specific antigen for recurrence after radical prostatectomy as a function of surgeon experience. International Journal of Cancer. 2011 Academic Article GET IT
Times cited: 4
Pathological results and rates of treatment failure in high-risk prostate cancer patients after radical prostatectomy. BJU International. 2011 Academic Article GET IT
Times cited: 93
Predicting 15-year prostate cancer specific mortality after radical prostatectomy. Journal of Urology. 2011 Academic Article GET IT
Times cited: 419
Variations Among Experienced Surgeons in Cancer Control After Open Radical Prostatectomy. Journal of Urology. 2010 Academic Article GET IT
Times cited: 45
Fellowship training as a modifier of the surgical learning curve. Academic Medicine. 2010 Academic Article GET IT
Times cited: 29
Location, Extent and Number of Positive Surgical Margins Do Not Improve Accuracy of Predicting Prostate Cancer Recurrence After Radical Prostatectomy. Journal of Urology. 2009 Academic Article GET IT
Times cited: 132
Prostate cancer-specific mortality after radical prostatectomy for patients treated in the prostate-specific antigen era. Journal of Clinical Oncology. 2009 Academic Article GET IT
Times cited: 326
Fibrils of prostatic acid phosphatase fragments boost infections with XMRV (Xenotropic Murine leukemia virus-Related Virus), a human retrovirus associated with prostate cancer. Journal of Virology. 2009 Academic Article GET IT
Times cited: 63
Comparison of Observed Biochemical Recurrence-free Survival in Patients With Low PSA Values Undergoing Radical Prostatectomy and Predictions of Preoperative Nomogram. Urology. 2009 Academic Article GET IT
Times cited: 10
Editorial Comment. Journal of Urology. 2009 Academic Article GET IT
A Multi-Institutional Evaluation of Active Surveillance for Low Risk Prostate Cancer. Journal of Urology. 2009 Academic Article GET IT
Times cited: 86
Preoperative and postoperative nomograms incorporating surgeon experience for clinically localized prostate cancer. Cancer. 2009 Academic Article GET IT
Times cited: 57
Surgeon Experience is Strongly Associated With Biochemical Recurrence After Radical Prostatectomy for All Preoperative Risk Categories. Journal of Urology. 2008 Academic Article GET IT
Times cited: 115
Effects of Pathologic Stage on the Learning Curve for Radical Prostatectomy: Evidence That Recurrence in Organ-Confined Cancer Is Largely Related to Inadequate Surgical Technique. European Urology. 2008 Academic Article GET IT
Times cited: 81
How Many Lymphadenectomies Does It Take to Cure One Patient?. European Urology. 2008 Editorial Article GET IT
Times cited: 19
The surgical learning curve for prostate cancer control after radical prostatectomy. Journal of the National Cancer Institute. 2007 Academic Article GET IT
Times cited: 295
Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy. Journal of Clinical Oncology. 2007 Academic Article GET IT
Times cited: 636
Complete Resection of Seminal Vesicles at Radical Prostatectomy Results in Substantial Long-Term Disease-Free Survival: Multi-institutional Study of 6740 Patients. Urology. 2007 Academic Article GET IT
Times cited: 34
An infectious retrovirus susceptible to an IFN antiviral pathway from human prostate tumors. Proceedings of the National Academy of Sciences of the United States of America. 2007 Academic Article GET IT
Times cited: 189
Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. Journal of Clinical Oncology. 2005 Academic Article GET IT
Times cited: 436
Age and PSA predict likelihood of organ-confined disease in men presenting with PSA less than 10 ng/mL: Implications for screening. Urology. 2003 Academic Article GET IT
Times cited: 35
Prostate-specific antigen as a marker of disease activity in prostate cancer. ONCOLOGY. 2002 Review GET IT
Times cited: 24
Prostate-specific antigen as a marker of disease activity in prostate cancer. ONCOLOGY. 2002 Review GET IT
Times cited: 27

VIVO Weill Cornell Medical College

Klein, Eric A. External Author

Publications

Selected publications